Shares of drug distributor Cencora COR.N fall 3.4% to $334 premarket
Cencora says James Cleary will retire as Chief Financial Officer effective June 30, 2026
Says it has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates
Cleary will assist in the search process and serve as an adviser through the end of 2026 - COR
Evercore ISI says "we view his continued involvement through the transition period as a positive, supporting continuity and execution"
Cencora also reaffirms previously issued annual adjusted EPS forecast of $17.45 to $17.75
Analysts expect annual adjusted EPS of $17.62 per share, according to data compiled by LSEG
As of last close, COR up 2.4% YTD